Literature DB >> 6154830

Plasma-separation in myasthenia gravis: a new method of rapid plasma exchange.

W Samtleben, U A Besinger, K V Toyka, A Fateh-Moghadam, G Brehm, H J Gurland.   

Abstract

A patient with myasthenic crisis was successfully treated with a new method of plasma exchange using a hollow-fiber filter connected to a standard dialysis pump. The filter allows PE to be performed at more clinical centers and probably at lower costs than current methods applying blood cell separators.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6154830     DOI： 10.1007/BF01477144

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  12 in total

1.  Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.

Authors:  A G Engel; E H Lambert; F M Howard
Journal:  Mayo Clin Proc       Date:  1977-05       Impact factor: 7.616

2.  Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.

Authors:  P C Dau; J M Lindstrom; C K Cassel; E H Denys; E E Shev; L E Spitler
Journal:  N Engl J Med       Date:  1977-11-24       Impact factor: 91.245

3.  Long-term effects of repeated plasma exchange in myasthenia gravis.

Authors:  J Newsom-Davis; S G Wilson; A Vincent; C D Ward
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

4.  Treatment of intractable ascites by continuous reinfusion of the sterilized, cell-free and concentrated ascitic fluid.

Authors:  N Inoue; Z Yamazaki; T Oda; M Sugiura; T Wada
Journal:  Trans Am Soc Artif Intern Organs       Date:  1977

5.  Myasthenia gravis: passive transfer from man to mouse.

Authors:  K V Toyka; D B Brachman; A Pestronk; I Kao
Journal:  Science       Date:  1975-10-24       Impact factor: 47.728

6.  Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.

Authors:  J Newsom-Davis; A J Pinching; A Vincent; S G Wilson
Journal:  Neurology       Date:  1978-03       Impact factor: 9.910

7.  Remission of myasthenia gravis following plasma-exchange.

Authors:  A J Pinching; D K Peters
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

8.  [The significance of determining antibodies to acetylcholine receptor in myasthenia gravis (author's transl)].

Authors:  K V Toyka; T Becker; A Fateh-Moghadam; U A Besinger; G Brehm; D Neumeier; K Heininger; K L Birnberger
Journal:  Klin Wochenschr       Date:  1979-09-17

9.  An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.

Authors:  J Lindstrom
Journal:  Clin Immunol Immunopathol       Date:  1977-01

10.  Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.

Authors:  J M Lindstrom; A G Engel; M E Seybold; V A Lennon; E H Lambert
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307
View more
  5 in total

1.  Treatment of chronic relapsing inflammatory demyelinating polyneuropathy by cyclosporin A and plasma exchange. A case report.

Authors:  H Hefter; K B Sprenger; G Arendt; D Hafner
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

Review 2.  Myasthenia gravis as a prototype autoimmune receptor disease.

Authors:  A C Hoedemaekers; P J van Breda Vriesman; M H De Baets
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

3.  Treatment of Guillain-Barré syndrome by plasma exchange.

Authors:  E Rumpl; U Mayr; F Gerstenbrand; J M Hackl; P Rosmanith; F Aichner
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

4.  Elimination kinetics of plasma exchange.

Authors:  F Keller; K Wagner; U Faber; J Scholle; H H Neumayer; M Maiga; G Schultze; G Offermann; M Molzahn
Journal:  Klin Wochenschr       Date:  1983-11-15

Review 5.  Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

Authors:  Nico Melzer; Tobias Ruck; Peter Fuhr; Ralf Gold; Reinhard Hohlfeld; Alexander Marx; Arthur Melms; Björn Tackenberg; Berthold Schalke; Christiane Schneider-Gold; Fritz Zimprich; Sven G Meuth; Heinz Wiendl
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.